Investigating the Potential of Conjugated Selenium Redox Folic Acid as a Treatment for Triple Negative Breast Cancer
Previous studies have demonstrated that redox selenium compounds arrest cancer cell viability in vitro through their pro-oxidative activity by generating superoxide (O<sub>2</sub><sup>•−</sup>). Currently, there are no efficacious treatment options for wom...
Saved in:
Main Authors: | Soni Khandelwal (Author), Mallory Boylan (Author), Gilbert Kirsch (Author), Julian E. Spallholz (Author), Lauren S. Gollahon (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chlorin Conjugates in Photodynamic Chemotherapy for Triple-Negative Breast Cancer
by: Meden F. Isaac-Lam
Published: (2024) -
Histopathological impact of Redox-responsive methacrylamide based micellar nanoparticles on Orthotopic Models of Triple Negative Breast Cancers
by: Fatemeh Mehradnia, et al.
Published: (2022) -
Tumor Microenvironment Responsive Nanomicelle with Folic Acid Modification Co-Delivery of Doxorubicin/Shikonin for Triple Negative Breast Cancer Treatment
by: Wu Zhong, et al.
Published: (2023) -
Biotinylated Polymer-Ruthenium Conjugates: In Vitro and In Vivo Studies in a Triple-Negative Breast Cancer Model
by: Leonor Côrte-Real, et al.
Published: (2022) -
Selenium Anticancer Properties and Impact on Cellular Redox Status
by: Lolita Kuršvietienė, et al.
Published: (2020)